Profile
Philippe Dupont worked as Director-Industrial Development at Novagali Pharma SA, Head-Logistics & Purchasing at Laboratoires Opodex, and Vice President-Pharmaceuticals Operations at Biophytis SA. He holds a doctorate degree from Université de Paris XI Paris Sud and an MBA from ESSEC Business School.
Former positions of Philippe Dupont
| Companies | Position | End |
|---|---|---|
Laboratoires Opodex
 Laboratoires Opodex Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Laboratoires Opodex is a pharmaceuticals manufacturer. The company is based in Villeneuve la Garenne, France. Laboratoires Opodex was acquired by Omega Pharma NV, part of Perrigo Co. Plc from March 30, 2015 on March 19, 2001. | Corporate Officer/Principal | - |
| BIOPHYTIS S.A. | Chief Operating Officer | - |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Corporate Officer/Principal | - |
Training of Philippe Dupont
| ESSEC Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOPHYTIS S.A. | Health Technology |
| Private companies | 3 |
|---|---|
Laboratoires Opodex
Laboratoires Opodex Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Laboratoires Opodex is a pharmaceuticals manufacturer. The company is based in Villeneuve la Garenne, France. Laboratoires Opodex was acquired by Omega Pharma NV, part of Perrigo Co. Plc from March 30, 2015 on March 19, 2001. | Health Technology |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
- Stock Market
- Insiders
- Philippe Dupont
